Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

12-Month Open-Label Extension Study of Intepirdine (RVT-101) in Subjects With Alzheimer's Disease: MINDSET Extension

ClinicalTrials.gov ID: NCT02586909

Public ClinicalTrials.gov record NCT02586909. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 4:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Long-Term, Open-Label Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Alzheimer's Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This 12-month open-label study will provide further information regarding the long-term safety and tolerability of intepirdine (RVT-101) for subjects with Alzheimer's disease who have completed the double-blind, placebo-controlled, lead-in study RVT-101-3001 (double-blind study).

Study identification

NCT ID
NCT02586909
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Axovant Sciences Ltd.
Industry
Enrollment
1,099 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
50 Years to 86 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 26, 2016 (Actual)
Primary completion
Mar 12, 2018 (Actual)
Completion
Mar 12, 2018 (Actual)
Last update posted
Apr 17, 2020

2016 – 2018

United States locations

U.S. sites
52
U.S. states
19
U.S. cities
49
Facility City State ZIP Site status
US112 Phoenix Arizona 85005 —
US220 Tucson Arizona 85704 —
US096 Rancho Mirage California 92270 —
US195 Santa Ana California 92705 —
US016 Simi Valley California 93065 —
US106 Temecula California 92591 —
US179 Hamden Connecticut 06518 —
US171 Norwich Connecticut 06360 —
US088 Atlantis Florida 33462 —
US007 Brooksville Florida 34601 —
US002 Hallandale Florida 33009 —
US140 Hialeah Florida 33012 —
US216 Miami Florida 33137 —
US110 Miami Florida 33165 —
US172 North Palm Beach Florida 33408 —
US003 Orlando Florida 32806 —
US256 Pensacola Florida 32502 —
US037 Tampa Florida 33613 —
US042 Tampa Florida 33613 —
US004 The Villages Florida 32162 —
US048 Atlanta Georgia 30331 —
US046 Atlanta Georgia 30342 —
US217 Columbus Georgia 31909 —
US111 Baton Rouge Louisiana 70808 —
US095 Shreveport Louisiana 71104 —
US116 Newton Massachusetts 02459 —
US174 Quincy Massachusetts 02169 —
US144 Hattiesburg Mississippi 39401 —
US094 Las Vegas Nevada 89113 —
US135 Berlin New Jersey 08009 —
US197 Lawrenceville New Jersey 08648 —
US215 Mount Arlington New Jersey 07856 —
US057 Paterson New Jersey 08759 —
US209 Toms River New Jersey 08755 —
US036 West Long Branch New Jersey 07764 —
US001 Albany New York 12208 —
US049 Brooklyn New York 11235 —
US097 New Hyde Park New York 11040 —
US044 New York New York 10022 —
US150 Chapel Hill North Carolina 27599 —
US185 Charlotte North Carolina 28270 —
US008 Cincinnati Ohio 45227 —
US113 Cleveland Ohio 44106 —
US119 Shaker Heights Ohio 44122 —
US134 Portland Oregon 97210 —
US169 Media Pennsylvania 19063 —
US162 Plains Pennsylvania 18075 —
US148 Willow Grove Pennsylvania 19001 —
US043 San Antonio Texas 78229 —
US143 Orem Utah 84058 —
US149 Charlottesville Virginia 22903 —
US170 Spokane Washington 99202 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 117 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02586909, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 17, 2020 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02586909 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →